Annual report pursuant to Section 13 and 15(d)

Note 9 - Stockholders' Deficit (Tables)

v3.19.2
Note 9 - Stockholders' Deficit (Tables)
12 Months Ended
Jun. 30, 2019
Stockholders' deficit:  
Schedule of Warrant Activity
   

Number of

Warrants

   

Weighted

Average

Exercise

Price Per

Warrant

   

Remaining

Contract

Term (# years)

 
Warrants outstanding and exercisable at June 30, 2018     174,079     $ 20.30       0.74  
Warrants issued     -     $ -       -  
Warrants exchanged     (7,996    14.80        -  
Warrants forfeited     (157,750 )   $ 19.93       -  
Warrants outstanding and exercisable at June 30, 2019     8,333     $ 20.00       0.25  

 

   

Number of

Warrants

   

Weighted

Average

Exercise

Price Per

Warrant

   

Remaining

Contract

Term (# years)

 
Warrants outstanding and exercisable at June 30, 2017     234,259     $ 19.70       0.12-1.55  
Warrants issued     -     $ -       -  
Warrants exchanged     (14,165 )   $ 6.00       -  
Warrants forfeited     (46,015 )   $ 21.50       -  
Warrants outstanding and exercisable at June 30, 2018     174,079     $ 20.30       0.74  
Schedule of Stock Option Activity
   

Number of

Shares

   

Weighted

Average

Exercise Price

   

Weighted

Average

Remaining

Contract

Term (# years)

 
Outstanding at June 30, 2018     350,726     $ 8.38       8.87  
Granted     245,027     $ 14.45       9.71  
Exercised     -     $ -       -  
Forfeited and cancelled     (15,582 )   $ 4.64       -  
Outstanding at June 30, 2019     580,171     $ 11.05       8.59  
Exercisable at June 30, 2019     303,611     $ 10.02       8.01  

 

   

Number of

Shares

   

Weighted

Average

Exercise Price

   

Weighted

Average

Remaining

Contract

Term (# years)

 
Outstanding at June 30, 2017     71,628     $ 11.00       7.09  
Granted     292,511     $ 7.80          
                         
Exercised     -        -          
Forfeited and cancelled     (13,413 )   $ 4.60          
Outstanding at June 30, 2018     350,726     $ 8.38       8.87  
Exercisable at June 30, 2018     139,169     $ 7.30       7.70  

 

Schedule of Stock-based Compensation
Years ended June 30,   2019     2018  
Research and development   $ 314,000     $ 96,000  
Selling and administrative     1,630,000       159,000  
Total stock-based compensation expense   $ 1,944,000     $ 255,000  
Schedule of Stock Options Valuation Assumptions
  2019   2018
Expected volatility     111.4% -112.2%       138% -143%
Risk free interest rate     2.43% - 2.45%       1.76% - 2.63%
Forfeiture rate     20%       20% -23%
Dividend yield     0%       0%
Expected term (years)     5.61        5